Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Circle’s EURC stablecoin gains over $110M in market cap this year

Circle’s EURC stablecoin gains over $110M in market cap this year

CryptobriefingCryptobriefing2026/07/17 18:24
By:Cryptobriefing

Circle’s euro-backed stablecoin EURC has roughly doubled in market capitalization since the start of the year, climbing from approximately $205 million to around $430 million. The token’s circulation now sits at approximately €378 million as of mid-July, with its share of the euro stablecoin market ballooning from about 17% a year ago to north of 40%.

MiCA did the heavy lifting

MiCA’s full enforcement in late 2024 and early 2025 created a compliance gauntlet that most euro stablecoin issuers couldn’t survive. The most notable casualty was Tether’s EURT, which exited the market rather than meet the new regulatory requirements.

Advertisement
window.sevioads = window.sevioads || []; var sevioads_preferences = []; sevioads_preferences[0] = {}; sevioads_preferences[0].zone = "de1434f5-fa9e-44a6-93c3-4c2439763717"; sevioads_preferences[0].adType = "banner"; sevioads_preferences[0].inventoryId = "c5700508-581b-472c-8fdd-a931cdbfc8e1"; sevioads_preferences[0].accountId = "1e47efc1-ec2d-4fca-a8b9-354e249e5095"; sevioads.push(sevioads_preferences);

Circle secured a French Electronic Money Institution license back in 2024, giving it a single regulatory passport to operate across the entire EU and European Economic Area. The supply numbers tell the story cleanly. EURC’s token supply grew from roughly 309 million at the end of 2025 to approximately 390 million in early 2026, nearly tripling in a compressed timeframe.

Multi-chain expansion and Base launch

Circle has been deploying EURC across multiple blockchain networks, including Ethereum and Solana. The most recent expansion landed on July 9, when EURC went live on Coinbase’s Base network.

Daily active addresses for EURC hit an all-time high of 1,760 shortly after the Base launch. The broader euro stablecoin market has reached record highs approaching $900 million as of mid-2026, with EURC commanding roughly 40–50% of that total.

What this means for investors

The institutional character of this growth is worth noting. The supply expansion and market cap gains appear driven by enterprise-level integrations rather than grassroots consumer adoption. The company has reportedly been building payment integrations with partners like Visa and exploring point-of-sale terminal support through Ingenico, which would push EURC into physical retail environments.

With the overall euro stablecoin market still under $1 billion, it remains a fraction of the dollar stablecoin market, which is measured in the hundreds of billions.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales